| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
6,321 |
5,783 |
$819K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,092 |
2,847 |
$259K |
| 99215 |
Prolong outpt/office vis |
1,199 |
1,113 |
$211K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
72 |
69 |
$14K |
| 99205 |
Prolong outpt/office vis |
49 |
43 |
$12K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
409 |
382 |
$8K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
56 |
54 |
$7K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
465 |
431 |
$7K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,334 |
1,248 |
$6K |
| 81001 |
|
2,150 |
1,996 |
$6K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
379 |
318 |
$6K |
| 0012A |
|
144 |
118 |
$4K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
296 |
154 |
$4K |
| 0011A |
|
126 |
120 |
$4K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
111 |
99 |
$3K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
138 |
133 |
$3K |
| 90686 |
|
289 |
278 |
$3K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
104 |
96 |
$2K |
| 90461 |
|
60 |
36 |
$2K |
| 36415 |
Collection of venous blood by venipuncture |
5,406 |
4,989 |
$1K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
40 |
39 |
$882.83 |
| 99201 |
|
12 |
12 |
$675.84 |
| 87400 |
|
29 |
25 |
$352.20 |
| 87301 |
|
14 |
14 |
$167.72 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
15 |
15 |
$151.19 |
| 80050 |
General health panel |
942 |
914 |
$149.38 |
| 90715 |
|
15 |
13 |
$97.42 |
| 82044 |
|
17 |
15 |
$87.92 |
| 80061 |
Lipid panel |
704 |
682 |
$42.86 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
345 |
230 |
$0.00 |
| 86328 |
|
445 |
213 |
$0.00 |
| 81003 |
|
162 |
154 |
$0.00 |
| 91301 |
|
355 |
313 |
$0.00 |
| 87070 |
|
25 |
24 |
$0.00 |